FDA clears emergency use of lab-made antibodies to treat COVID-19

  • November 22, 2020
The FDA just cleared a medical advance that could play an important (if limited) role in treating COVID-19 patients. The administration has granted emergency use authorization for Regeneron’s lab-made monoclonal antibodies (a combo of casirivimab and…